{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:34:58Z","timestamp":1790494498064,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Bristol Myers Squibb"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s40744-022-00427-y","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T16:02:42Z","timestamp":1645027362000},"page":"637-647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Role of Shared Epitope in Rheumatoid Arthritis Prognosis in Relation to Anti-Citrullinated Protein Antibody Positivity"],"prefix":"10.1007","volume":"9","author":[{"given":"Joe","family":"Zhuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niyati","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonie","family":"Lama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivi","family":"Feathers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Shadick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Weinblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"key":"427_CR1","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Aletaha D, Barton A, et al. Rheumatoid arthritis. Nat Rev Dis Prim. 2018;4:18001.","journal-title":"Nat Rev Dis Prim"},{"key":"427_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nri1838","volume":"6","author":"JC Edwards","year":"2006","unstructured":"Edwards JC, Cambridge G. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol. 2006;6:394\u2013403.","journal-title":"Nat Rev Immunol"},{"key":"427_CR3","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205\u201319.","journal-title":"N Engl J Med"},{"key":"427_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/BOR.0000000000000452","volume":"30","author":"E Darrah","year":"2018","unstructured":"Darrah E, Andrade F. Rheumatoid arthritis and citrullination. Curr Opin Rheumatol. 2018;30:72\u20138.","journal-title":"Curr Opin Rheumatol"},{"key":"427_CR5","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantapaa-Dahlqvist","year":"2003","unstructured":"Rantapaa-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48:2741\u20139.","journal-title":"Arthritis Rheum"},{"key":"427_CR6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen JS, Landewe RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79:685\u201399.","journal-title":"Ann Rheum Dis"},{"key":"427_CR7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.5114\/ceji.2017.72807","volume":"42","author":"W Kurowska","year":"2017","unstructured":"Kurowska W, Kuca-Warnawin EH, Radzikowska A, Maslinski W. The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis. Cent Eur J Immunol. 2017;42:390\u20138.","journal-title":"Cent Eur J Immunol"},{"key":"427_CR8","doi-asserted-by":"publisher","first-page":"R160","DOI":"10.1186\/ar3479","volume":"13","author":"PW Meyer","year":"2011","unstructured":"Meyer PW, Hodkinson B, Ally M, et al. HLA-DRB1 shared epitope genotyping using the revised classification and its association with circulating autoantibodies, acute phase reactants, cytokines and clinical indices of disease activity in a cohort of South African rheumatoid arthritis patients. Arthritis Res Ther. 2011;13:R160.","journal-title":"Arthritis Res Ther"},{"key":"427_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/acr.23250","volume":"70","author":"E Alemao","year":"2018","unstructured":"Alemao E, Bryson J, Iannaccone CK, Frits M, Shadick NA, Weinblatt M. Association of shared epitope and poor prognostic factors in RA. Arthritis Rheumatol. 2018;70:71.","journal-title":"Arthritis Rheumatol"},{"key":"427_CR10","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/art.1780301102","volume":"30","author":"PK Gregersen","year":"1987","unstructured":"Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987;30:1205\u201313.","journal-title":"Arthritis Rheum"},{"key":"427_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ng.1076","volume":"44","author":"S Raychaudhuri","year":"2012","unstructured":"Raychaudhuri S, Sandor C, Stahl EA, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet. 2012;44:291\u20136.","journal-title":"Nat Genet"},{"key":"427_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/art.38927","volume":"67","author":"X Jiang","year":"2015","unstructured":"Jiang X, Frisell T, Askling J, et al. To what extent is the familial risk of rheumatoid arthritis explained by established rheumatoid arthritis risk factors? Arthritis Rheumatol. 2015;67:352\u201362.","journal-title":"Arthritis Rheumatol"},{"key":"427_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA\u2013DR (shared epitope)\u2013restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54:38\u201346.","journal-title":"Arthritis Rheum"},{"issue":"52","key":"427_CR14","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1002\/art.21385","volume":"2005","author":"TW Huizinga","year":"2005","unstructured":"Huizinga TW, Amos CI, Helm-van AH, et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum. 2005;2005(52):3433\u20138.","journal-title":"Arthritis Rheum"},{"key":"427_CR15","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1002\/art.39105","volume":"67","author":"C Terao","year":"2015","unstructured":"Terao C, Yano K, Ikari K, et al. Brief report: main contribution of DRB1*04:05 among the shared epitope alleles and involvement of DRB1 amino acid position 57 in association with joint destruction in anti\u2013citrullinated protein antibody\u2013positive rheumatoid arthritis. Arthritis Rheumatol. 2015;67:1744\u201350.","journal-title":"Arthritis Rheumatol"},{"key":"427_CR16","first-page":"6","volume":"23","author":"I Moreno","year":"1996","unstructured":"Moreno I, Valenzuela A, Garcia A, Yelamos J, Sanchez B, Hernanz W. Association of the shared epitope with radiological severity of rheumatoid arthritis. J Rheumatol. 1996;23:6\u20139.","journal-title":"J Rheumatol"},{"key":"427_CR17","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1002\/art.20555","volume":"50","author":"H Wu","year":"2004","unstructured":"Wu H, Khanna D, Park G, et al. Interaction between RANKL and HLA-DRB1 genotypes may contribute to younger age at onset of seropositive rheumatoid arthritis in an inception cohort. Arthritis Rheum. 2004;50:3093\u2013103.","journal-title":"Arthritis Rheum"},{"key":"427_CR18","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3899\/jrheum.081075","volume":"36","author":"S Reneses","year":"2009","unstructured":"Reneses S, Gonz\u00e1lez-Escribano MF, Fern\u00e1ndez-Su\u00e1rez A, et al. The value of HLA-DRB1 shared epitope, \u2212308 tumor necrosis factor-\u03b1 gene promoter polymorphism, rheumatoid factor, anti-citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent-onset rheumatoid arthritis. J Rheumatol. 2009;36:1143\u20139.","journal-title":"J Rheumatol"},{"key":"427_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/art.23149","volume":"58","author":"TM Farragher","year":"2008","unstructured":"Farragher TM, Goodson NJ, Naseem H, et al. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum. 2008;58:359\u201369.","journal-title":"Arthritis Rheum"},{"key":"427_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nri.2016.124","volume":"17","author":"V Malmstrom","year":"2017","unstructured":"Malmstrom V, Catrina AI, Klareskog L. The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting. Nat Rev Immunol. 2017;17:60\u201375.","journal-title":"Nat Rev Immunol"},{"key":"427_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheumatol. 1988;31:315\u201324.","journal-title":"Arthritis Rheumatol"},{"key":"427_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3899\/jrheum.121521","volume":"41","author":"VP Bykerk","year":"2014","unstructured":"Bykerk VP, Shadick N, Frits M, et al. Flares in rheumatoid arthritis: frequency and management. A report from the BRASS registry. J Rheumatol. 2014;41:227\u201334.","journal-title":"J Rheumatol"},{"key":"427_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/rheumatology\/keq263","volume":"50","author":"CK Iannaccone","year":"2011","unstructured":"Iannaccone CK, Lee YC, Cui J, et al. Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women\u2019s Hospital Rheumatoid Arthritis Sequential Study. Rheumatology (Oxford). 2011;50:40\u20136.","journal-title":"Rheumatology (Oxford)"},{"key":"427_CR24","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/acr.21940","volume":"65","author":"CK Iannaccone","year":"2013","unstructured":"Iannaccone CK, Fossel A, Tsao H, Cui J, Weinblatt M, Shadick N. Factors associated with attrition in a longitudinal rheumatoid arthritis registry. Arthritis Care Res (Hoboken). 2013;65:1183\u20139.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"427_CR25","unstructured":"International Society for Pharmacoepidemiology. Guidelines for good pharmacoepidemiology practices (GPP) 2016. Accessed 7 Jul 2016. Available from: https:\/\/www.pharmacoepi.org\/resources\/policies\/guidelines-08027\/."},{"key":"427_CR26","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1136\/annrheumdis-2020-eular.4153","volume":"79","author":"J Zhuo","year":"2020","unstructured":"Zhuo J, Bryson J, Xia Q, et al. Role of shared epitope in the prognosis of rheumatoid arthritis in relation to ACPA positivity. Ann Rheum Dis. 2020;79:963 (SAT0061).","journal-title":"Ann Rheum Dis"},{"key":"427_CR27","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/art.20006","volume":"50","author":"JD Gorman","year":"2004","unstructured":"Gorman JD, Lum RF, Chen JJ, Suarez-Almazor ME, Thomson G, Criswell LA. Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum. 2004;50:400\u201312.","journal-title":"Arthritis Rheum"},{"key":"427_CR28","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.autrev.2017.10.002","volume":"16","author":"EG Favalli","year":"2017","unstructured":"Favalli EG, Raimondo MG, Becciolini A, Crotti C, Biggioggero M, Caporali R. The management of first-line biologic therapy failures in rheumatoid arthritis: current practice and future perspectives. Autoimmun Rev. 2017;16:1185\u201395.","journal-title":"Autoimmun Rev"},{"key":"427_CR29","doi-asserted-by":"publisher","first-page":"1759720x2110609","DOI":"10.1177\/1759720X211060910","volume":"13","author":"P Bogas","year":"2021","unstructured":"Bogas P, Plasencia-Rodriguez C, Navarro-Comp\u00e1n V, et al. Comparison of long-term efficacy between biological agents following tumor necrosis factor inhibitor failure in patients with rheumatoid arthritis: a prospective cohort study. Ther Adv Musculoskelet Dis. 2021;13:1759720x211060910.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"427_CR30","first-page":"1000","volume":"79","author":"J Zhuo","year":"2020","unstructured":"Zhuo J, Bryson J, Xia Q, et al. Role of shared epitope on the effectiveness of TNFi treatment for patients with rheumatoid arthritis. Ann Rheum Dis. 2020;79:1000\u20131 (abstract SAT0129).","journal-title":"Ann Rheum Dis"},{"key":"427_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3899\/jrheum.170007","volume":"45","author":"LR Harrold","year":"2018","unstructured":"Harrold LR, Litman HJ, Connolly SE, et al. Effect of anticitrullinated protein antibody status on response to abatacept or antitumor necrosis factor-alpha therapy in patients with rheumatoid arthritis: a US national observational study. J Rheumatol. 2018;45:32\u20139.","journal-title":"J Rheumatol"},{"key":"427_CR32","first-page":"abstract 1034","volume":"69","author":"E Alemao","year":"2017","unstructured":"Alemao E, Postema R, Elbez Y, Mamane C, Finckh A. Presence of anti-cyclic citrullinated peptide antibodies is associated with better treatment response to abatacept but not to TNF inhibitors in patients with RA: a meta-analysis. Arthritis Rheumatol. 2017;69:abstract 1034.","journal-title":"Arthritis Rheumatol"},{"key":"427_CR33","first-page":"1234","volume":"77","author":"K Oryoji","year":"2018","unstructured":"Oryoji K, Yoshida K, Kashiwado Y, et al. Shared epitope positivity is related to efficacy of abatacept in rheumatoid arthritis. Ann Rheum Dis. 2018;77:1234\u20136.","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-022-00427-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-022-00427-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-022-00427-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T08:11:02Z","timestamp":1648541462000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-022-00427-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["427"],"URL":"https:\/\/doi.org\/10.1007\/s40744-022-00427-y","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,16]]},"assertion":[{"value":"13 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}